What has been the experience of others taking Kisqali (ribociclib) to prevent recurrence for Stage 2, Grade 3 ER/PR+ breast cancer?
First, congratulations on getting through your mastectomy — four weeks out is still early days, so be kind to yourself! 💪
Kisqali combined with an aromatase inhibitor is a well-established Show Full Answer
What has been the experience of others taking Kisqali (ribociclib) to prevent recurrence for Stage 2, Grade 3 ER/PR+ breast cancer?
First, congratulations on getting through your mastectomy — four weeks out is still early days, so be kind to yourself! 💪
Kisqali combined with an aromatase inhibitor is a well-established approach for HR-positive breast cancer. Research has shown that Kisqali can meaningfully reduce the risk of recurrence for people with HR-positive breast cancer like yours. Many MyBCTeam members have shared their experiences with Kisqali. Common things reported include:
- Fatigue — feeling more tired than usual, especially in the first cycle
- Nausea — often manageable, particularly when taken with food
- Low white blood cell counts — your care team will monitor this with regular blood tests
- Hair thinning — some members notice this, though it varies widely
- Mouth sores — less common but worth mentioning to your doctor if they occur
Everyone's experience is different, and many members find side effects become more manageable after the first few cycles as the body adjusts. It's really important to flag any side effects to your oncology team promptly, as they can often adjust timing, dosage, or offer supportive care to help you stay on track with treatment.
Staying on your hormonal therapy plan is key — it significantly reduces recurrence risk for ER/PR+ breast cancer. You're in good hands! 🌟
July 2
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
